52727 Efficacy and Safety of Sarecycline in Chinese Patients with Acne Vulgaris: A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Phase-3 Trial

Introduction: Sarecycline is a novel, narrow-spectrum, tetracycline-derived antibiotic approved in the US for the treatment of moderate-to-severe acne vulgaris in patients aged ≥9 years [1, 2].